Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance).
      Google Scholar   
Citation:
J. Natl. Cancer Inst. vol 112 (7) 737-46
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
No
Book Volume:
9
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
Astra Zeneca; Novartis; Pfizer  
Grants:
PG12220321, RR140033, U10CA180821, U10CA180882, U10CA180833, U10CA180858, U24CA196171  
Corr. Author:
 
Authors:
                           
Study
ACOSOG-Z1031
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2/3
Keywords: